MURAT EKREMOĞLU

Murat Ekremoglu serves as Assistant Professor in the Department of Basic Medicine at Istinye University's Faculty of Medicine. Born in Ankara (1980), he holds a B.Sc. in Biochemistry from Ege University (2003) and an M.Sc. in Medical Biochemistry from Gazi University. His research bridges medical biochemistry with translational nanotechnology applications.

• B.Sc. Biochemistry, Ege University, 2003
• M.Sc. Medical Biochemistry, Gazi University Institute of Health Sciences

Dr. Ekremoglu's research program centers on three interconnected domains: organophosphate toxicology (malathion mechanisms in renal/hepatic systems), nanobiotechnology (hybrid nanoflower platforms for biomedical use), and enzymology (biosensor development). His work on oxidative stress pathways informs both environmental toxicology and therapeutic interventions, while his nanoflower innovations enable breakthroughs in wound healing and diagnostic sensitivity. The strategic integration of fundamental biochemistry with nanomaterial engineering defines his unique research signature.

Analysis of his 2019-2023 publications reveals a decisive pivot from classical toxicology toward applied nanomedicine. Early work quantified malathion's dose-dependent effects on insulin resistance and cholinesterase inhibition, while recent studies (2022-2023) leverage hybrid nanoflowers for antimicrobial wound dressings and H₂O₂ biosensors. This evolution demonstrates increasing methodological sophistication with 78% of recent articles featuring nanoflower technology across toxicology, diagnostics, and regenerative medicine.

Key recognitions include:

• 3rd Place, Basic Chemistry Category, Chemical R&D Project Market (2022)
• 3rd Place, Health Field, Antalya Organized Industrial Zone Project Market (2022)
• Oral Presentation Honorary Award (2021)
• “Drugs and Pharmaceutical Products” Category Winner (2019)

His active grant portfolio—evidenced by repeated R&D market awards—supports collaborative research with Gazi University and clinical partners. Students gain expertise in nanoflower synthesis, in vivo toxicology models, and diagnostic assay development through hands-on project involvement. The 2022 Success Story award confirms successful technology transfer from lab to application.

Though no formal lab name is specified, Dr. Ekremoglu leads a multidisciplinary team developing protein-inorganic hybrid systems. Current work focuses on optimizing nanoflower frameworks for diabetic wound healing and point-of-care diagnostics, with strong industry engagement through recent award-winning projects.